Mecoblend-PSR Tablet is a combination pharmaceutical formulation containing Methylcobalamin 1500 mcg and Pregabalin 75 mg, indicated for the management of neuropathic pain and associated neurological disorders. Methylcobalamin, an active form of vitamin B12, plays a crucial role in nerve regeneration and repair by promoting myelin sheath synthesis and enhancing neuronal function. Pregabalin, an anticonvulsant and analgesic agent, modulates calcium channel function in the central nervous system, thereby reducing neurotransmitter release and alleviating neuropathic pain, seizures, and anxiety symptoms. The synergistic effect of these two components provides effective relief from peripheral neuropathy, diabetic neuropathy, postherpetic neuralgia, and other neuropathic conditions. Mecoblend-PSR is also beneficial in improving nerve conduction velocity and reducing symptoms such as burning, tingling, numbness, and shooting pain. The recommended dosage should be individualized based on clinical response and tolerability, with caution advised in patients with renal impairment. Common adverse effects may include dizziness, somnolence, gastrointestinal disturbances, and allergic reactions. Mecoblend-PSR Tablet should be used under medical supervision, with attention to contraindications such as hypersensitivity to either component. This combination therapy offers a comprehensive approach to neuropathic pain management by addressing both symptomatic relief and underlying nerve repair mechanisms.